Literature DB >> 2813376

Abnormal processing of multiple proteins in Alzheimer disease.

H Zhang1, N H Sternberger, L J Rubinstein, M M Herman, L I Binder, L A Sternberger.   

Abstract

Cerebrovascular amyloid is the main constituent of the perivascular and neuritic plaques typical of Alzheimer disease, whereas neurofilaments and microtubule-associated tau protein have been considered primary contributors to the formation of the characteristic Alzheimer tangles. Plaques and tangles and their constituents have at times been ascribed a role in pathogenesis of the disease. Normally, neurofilaments become phosphorylated only upon axonal entry. In many neurologic disorders, neurofilament phosphorylation, as detected by any of the available monoclonal antibodies (mAbs) to neurofilament phosphorylated epitopes is shifted from an axonal to a cell-body location. An exception is provided by Alzheimer disease, where tangles (which are neuronal cell-body-derived structures) exhibit only one phosphorylated epitope. However, the very presence of neurofilaments in tangles and plaques has been questioned because of a reported cross-reaction of mAbs to phosphorylated neurofilaments with tau protein. On reinvestigating this cross-reactivity we found that four of five mAbs to phosphorylated neurofilaments and four of five mAbs to nonphosphorylated neurofilaments failed to react with tau protein. A fifth mAb (07-5) to phosphorylated neurofilament cross-reacted with partially denatured tau protein at an affinity 1/1700th of that for denatured neurofilaments; nondenatured tau protein in tissue sections did not cross-react. A fifth mAb (02-40) to nonphosphorylated neurofilament also cross-reacted weakly. In Alzheimer disease normal-appearing axons were revealed with all the mAbs to phosphorylated neurofilaments, but tangles were revealed with only one of them (mAb 07-5). mAb to tau protein did not stain or did so indistinctly. Four of five mAbs to nonphosphorylated neurofilaments failed to reveal axons. Upon dephosphorylation of tissue, staining by mAbs to phosphorylated neurofilaments disappeared, and axons were revealed with the mAb to tau protein and all mAbs to the nonphosphorylated neurofilaments. Tangles became stained with tau mAb and one mAb to the nonphosphorylated neurofilaments (mAb 10-1). Quantitative evaluation of immunocytochemical staining intensities and immunoblot cross-reactivity showed that neurofilaments are, indeed, constituents of tangles--apparently exceeding the concentration of tau protein 17-fold. Contribution of both conformation and primary structure to IgG specificity may explain the lack of any cross-reaction of mAbs to neurofilaments with tau protein in intact tissue and the appearance of cross-reaction in immunoblots where conformation specificity may be largely lost. The present data extend earlier findings of abnormal processing of neurofilaments and tau protein in Alzheimer disease and, together with reported abnormal processing of cerebrovascular amyloid beta-protein, suggest that inhibition of the processing of multiple proteins is basic to the pathogenesis of Alzheimer disease, whereas formation of plaques and tangles could be merely the most striking histologic result.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813376      PMCID: PMC298211          DOI: 10.1073/pnas.86.20.8045

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  A critical review of immunocytochemical methods for light microscopy.

Authors:  F Vandesande
Journal:  J Neurosci Methods       Date:  1979-03       Impact factor: 2.390

2.  Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease.

Authors:  D Allsop; C W Wong; S Ikeda; M Landon; M Kidd; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 3.  Alzheimer's disease: its proteins and genes.

Authors:  G G Glenner
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

4.  The purification of tau protein and the occurrence of two phosphorylation states of tau in brain.

Authors:  G Lindwall; R D Cole
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

5.  Immunocytochemistry of brain-reactive monoclonal antibodies in peripheral tissues.

Authors:  E Ostermann; N H Sternberger; L A Sternberger
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

6.  Effects of primary antiserum dilution on staining of "antigenrich" tissues with the peroxidase antiperoxidase technique.

Authors:  J W Bigbee; J C Kosek; L F Eng
Journal:  J Histochem Cytochem       Date:  1977-06       Impact factor: 2.479

7.  Amino acid substitution and the antigenicity of globular proteins.

Authors:  M Reichlin
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

8.  IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts.

Authors:  P J Gearhart; N D Johnson; R Douglas; L Hood
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

9.  Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

Authors:  L A Sternberger; N H Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Hemagglutinin of swine influenza virus: a single amino acid change pleiotropically affects viral antigenicity and replication.

Authors:  G W Both; C H Shi; E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

View more
  19 in total

1.  Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation.

Authors:  B S Li; L Zhang; J Gu; N D Amin; H C Pant
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5.

Authors:  M K Ahlijanian; N X Barrezueta; R D Williams; A Jakowski; K P Kowsz; S McCarthy; T Coskran; A Carlo; P A Seymour; J E Burkhardt; R B Nelson; J D McNeish
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 3.  Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.

Authors:  K Iqbal; I Grundke-Iqbal
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

4.  Absence of the 40-kDa form of (2'-5')oligoadenylate synthetase and its corresponding mRNA from skin fibroblasts derived from Alzheimer disease patients.

Authors:  K K Khanna; S J An; J M Wu; S Landolfo; A G Hovanessian
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

5.  Ubiquitin is a component of polypeptides purified from corpora amylacea of aged human brain.

Authors:  S Cissé; G Lacoste-Royal; J Laperrière; T Cabana; D Gauvreau
Journal:  Neurochem Res       Date:  1991-04       Impact factor: 3.996

6.  Immunocytochemical and ultrastructural studies of Werdnig-Hoffmann disease.

Authors:  S Murayama; T W Bouldin; K Suzuki
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ.

Authors:  Parvathi Rudrabhatla; Philip Grant; Howard Jaffe; Michael J Strong; Harish C Pant
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

Review 8.  Alois Alzheimer revisited: differences in origin of the disease carrying his name.

Authors:  K Maurer; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-23       Impact factor: 3.575

9.  Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells.

Authors:  M L Bush; J S Miyashiro; V M Ingram
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

10.  Spatio-temporal changes in neurofilament proteins immunoreactivity following kainate-induced cerebellar lesion in rats.

Authors:  I Milenkovic; R Filipovic; N Nedeljkovic; S Pekovic; M Culic; L Rakic; M Stojiljkovic
Journal:  Cell Mol Neurobiol       Date:  2004-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.